2024-2030 年全球藥用輔料市場

由於對改善藥物溶解度、穩定性、生物有效性和依從性的輔料的需求不斷增加，以患者為中心的配方將經歷急劇成長

Frost & Sullivan 的報告分析了全球藥用輔料市場，重點關注北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 (MEA) 等主要區域市場。報告對口服輔料、注射輔料、外用輔料、吸入輔料和眼用輔料等各個細分市場進行了定性和定量分析。口服輔料細分市場進一步分為口服固體和口服液體。人口老化和疾病數量的增加推動了所有治療領域對多樣化藥物製劑的需求。口服給藥因其成本效益和更高的患者依從性而成為最受歡迎的給藥方式。然而，預計吸入給藥將在預測期內實現最大成長。這項研究提供了對預測期內影響產業的市場動態的透徹理解。它分析了市場成長的促進因素和限制因素，並確定了該領域變化帶來的機會，以便市場參與者和相關人員能夠利用這些機會。報告的基準年為2024年，預測期間為2025年至2030年。

目錄

成長機會：研究範圍

• 分析範圍
• 研究範圍和細分
• 定義

成長環境：藥用輔料市場的轉型

• 為何成長變得越來越困難？
• The Strategic Imperative 8（TM）
• 三大策略要務對藥用輔料產業的影響

藥用輔料市場生態系統

• 價值鏈
• 競爭環境
• 主要競爭對手
• 競爭基準化分析– 口頭（固體）
• 競爭基準化分析－口服給藥（液體）
• 競爭基準化分析- 注射劑
• 競爭性基準化分析– 專題
• 競爭基準化分析- 吸入
• 競爭基準化分析- 眼藥水
• 市場活動 - 發布、併購、夥伴關係、擴張（2022-2024）

藥用輔料市場成長引擎

• 成長指標
• 成長動力
• 成長動力分析
• 成長抑制因素
• 成長抑制因素分析
• 預測考慮因素
• 收益預測
• 收益預測分析
• 按類型分類的收益預測
• 按類型分類的收益預測分析
• 各地區收益預測
• 各地區收益預測分析
• 價格趨勢及預測分析
• 收益佔有率

生長促進劑：口服給藥載體

• 成長指標
• 收益預測
• 收益預測分析
• 按類型分類的收益預測
• 口服固體收益預測（按類型）
• 按子類型分類的收益預測 -粘合劑和填充劑
• 塗料子類型收益預測
• 按子類型分類的收益預測 -崩壞
• 口服固體收益預測（按類型）
• 口服液產品收益預測（按類型）
• 按類型預測 - 口服液
• 各地區收益預測
• 區域預測分析

生長促進劑：注射輔料

• 成長指標
• 收益預測
• 收益預測分析
• 收益預測
• 按類型分類的收益分析 - 注射劑
• 各地區收益預測
• 區域預測分析 - 注射劑

成長動力：熱門載體

• 成長指標
• 收益預測
• 收益預測分析
• 收益預測
• 按類型進行預測分析 - 主題
• 各地區收益預測
• 區域預測分析 - 專題

生長促進劑：吸入輔料

• 成長指標
• 收益預測
• 收益預測分析
• 收益預測
• 按類型預測分析 - 吸入
• 各地區收益預測
• 區域預測分析 - 吸入

成長動力：眼科輔料

• 成長指標
• 收益預測
• 收益預測分析
• 收益預測
• 按類型預測分析 - 眼科
• 各地區收益預測
• 區域預測分析 - 眼科

藥用輔料市場的成長機會

• 成長機會1：新型輔料開發的獨立核准途徑
• 成長機會二：吸入式生物製劑
• 成長機會3：以病人為中心的配方

附錄與後續步驟

• 成長機會的益處和影響
• 後續步驟Next steps
• 文件清單
• 免責聲明

Patient-centric Formulations are Experiencing Transformational Growth Due to Increased Demand for Excipients that Improve Drug Solubility, Stability, Bioavailability, and Compliance

This Frost & Sullivan report analyzes the global pharmaceutical excipients market, with a focus on key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). The report provides both qualitative and quantitative analyses of various segments, including oral dosage excipients, injectable excipients, topical excipients, inhalable excipients, and ophthalmic excipients. The oral dosage excipients segment is further divided into the oral solid excipients and oral liquid excipients. Population aging, combined with a rising prevalence of diseases, is driving demand for diverse drug dosage formulations across all therapeutic areas. The oral route of drug administration is the most preferred due to its cost-effectiveness and better patient compliance. However, the inhalable route is expected to account for the most significant growth during the forecast period. This study offers a thorough understanding of the market dynamics that will shape the industry over the forecast period. It analyzes the factors driving and restraining market growth and identifies opportunities that arise from the changes in this space for market players and stakeholders to leverage. The base year for this report is 2024, while the forecast period extends from 2025 to 2030.

Table of Contents

Growth Opportunities: Research Scope

• Scope of Analysis
• Scope and Segmentation
• Definitions

Growth Environment: Transformation in the Pharmaceutical Excipients Market

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Excipients Industry

Ecosystem in the Pharmaceutical Excipients Market

• Value Chain
• Competitive Environment
• Key Competitors
• Competitive Benchmarking-Oral Solid Dosages
• Competitive Benchmarking-Oral Liquid Dosages
• Competitive Benchmarking-Injectable
• Competitive Benchmarking-Topical
• Competitive Benchmarking-Inhalable
• Competitive Benchmarking-Ophthalmic
• Market Activities-Launches, M&As, Partnerships, and Expansions, 2022-2024

Growth Generators in the Pharmaceutical Excipients Market

• Growth Metrics
• Growth Drivers
• Growth Driver Analysis
• Growth Restraints
• Growth Restraint Analysis
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Type
• Revenue Forecast Analysis by Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Pricing Trends and Forecast Analysis
• Revenue Share

Growth Generator: Oral Dosage Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Type
• Revenue Forecast by Type-Oral Solids
• Revenue Forecast by Sub-type-Binders and Fillers
• Revenue Forecast by Sub-type-Coatings
• Revenue Forecast by Sub-type-Disintegrants
• Forecast Analysis by Type-Oral Solids
• Revenue Forecast by Type-Oral Liquids
• Forecast Analysis by Type-Oral Liquids
• Revenue Forecast by Region
• Forecast Analysis by Region

Growth Generator: Injectable Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Injectables
• Revenue Forecast by Region
• Forecast Analysis by Region-Injectables

Growth Generator: Topical Excipient

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Topical
• Revenue Forecast by Region
• Forecast Analysis by Region-Topical

Growth Generator: Inhalable Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Inhalable
• Revenue Forecast by Region
• Forecast Analysis by Region-Inhalable

Growth Generator: Ophthalmic Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Ophthalmic
• Revenue Forecast by Region
• Forecast Analysis by Region-Ophthalmic

Growth Opportunity Universe in the Pharmaceutical Excipients Market

• Growth Opportunity 1: Independent Approval Pathway for the Development of Novel Excipients
• Growth Opportunity 2: Inhaled Biologics
• Growth Opportunity 3: Patient-centric Formulations

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer